Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenylate kinase 6 pseudogene 2 (AK6P2) is a genomic DNA sequence resembling the adenylate kinase 6 (AK6) gene but does not encode a functional protein. It is annotated as a pseudogene in genomic databases, indicating it is a non-coding gene copy that likely arose from duplication or retrotransposition and accumulated disabling mutations. Unlike its parent gene AK6, which encodes a nuclear-localized enzyme involved in nucleotide metabolism and cell energetics, AK6P2 has no evidence supporting its role as a therapeutic target, enzyme, transporter, receptor, or disease biomarker. Additional details: - Canonical target confusion: Although AK6 is biologically active and linked to several crucial cell processes, AK6P2 does not code for a functional protein and so is not a valid therapeutic target. - Nomenclature: The presence of “pseudogene” in the name indicates that AK6P2 should not be confused with AK6 (adenylate kinase 6), which is the actual protein-coding gene and potential target. - Aliases: There are no notable alternative names beyond "AK6P2".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylate kinase 6 pseudogene 2 (AK6P2).